These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20978062)

  • 21. Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England.
    Pierce M; Bird SM; Hickman M; Marsden J; Dunn G; Jones A; Millar T
    Addiction; 2016 Feb; 111(2):298-308. PubMed ID: 26452239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supervised dosing with a long-acting opioid medication in the management of opioid dependence.
    Saulle R; Vecchi S; Gowing L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011983. PubMed ID: 28447766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
    Heidebrecht F; MacLeod MB; Dawkins L
    Addict Behav; 2018 Feb; 77():210-216. PubMed ID: 29065377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales.
    Marteau D; McDonald R; Patel K
    BMJ Open; 2015 May; 5(5):e007629. PubMed ID: 26024998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients.
    Soyka M; Apelt SM; Lieb M; Wittchen HU
    J Clin Psychopharmacol; 2006 Dec; 26(6):657-60. PubMed ID: 17110826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder.
    Wang L; Volkow ND; Berger NA; Davis PB; Kaelber DC; Xu R
    J Clin Psychol; 2023 Dec; 79(12):2869-2883. PubMed ID: 37584532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales.
    Strang J; Sheridan J; Hunt C; Kerr B; Gerada C; Pringle M
    Br J Gen Pract; 2005 Jun; 55(515):444-51. PubMed ID: 15970068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting.
    Nolan S; Hayashi K; Milloy MJ; Kerr T; Dong H; Lima VD; Lappalainen L; Montaner J; Wood E
    Drug Alcohol Depend; 2015 Nov; 156():57-61. PubMed ID: 26455554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders.
    Carney T; Van Hout MC; Norman I; Dada S; Siegfried N; Parry CD
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012254. PubMed ID: 32068247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial.
    Wright NM; Sheard L; Adams CE; Rushforth BJ; Harrison W; Bound N; Hart R; Tompkins CN
    Br J Gen Pract; 2011 Dec; 61(593):e772-80. PubMed ID: 22137413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.
    Toce MS; Chai PR; Burns MM; Boyer EW
    J Med Toxicol; 2018 Dec; 14(4):306-322. PubMed ID: 30377951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.
    Tsui JI; Evans JL; Lum PJ; Hahn JA; Page K
    JAMA Intern Med; 2014 Dec; 174(12):1974-81. PubMed ID: 25347412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality and causes of death among users of methadone maintenance treatment in Israel, 1999-2008.
    Rosca P; Haklai Z; Goldberger N; Zohar P; Margolis A; Ponizovsky AM
    Drug Alcohol Depend; 2012 Sep; 125(1-2):160-3. PubMed ID: 22483811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.
    Degenhardt L; Randall D; Hall W; Law M; Butler T; Burns L
    Drug Alcohol Depend; 2009 Nov; 105(1-2):9-15. PubMed ID: 19608355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Road traffic crashes and prescribed methadone and buprenorphine: a French registry-based case-control study.
    Corsenac P; Lagarde E; Gadegbeku B; Delorme B; Tricotel A; Castot A; Moore N; Philip P; Laumon B; Orriols L
    Drug Alcohol Depend; 2012 Jun; 123(1-3):91-7. PubMed ID: 22104480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of drug-related mortality during periods of transition in methadone maintenance treatment: a cohort study.
    Cousins G; Teljeur C; Motterlini N; McCowan C; Dimitrov BD; Fahey T
    J Subst Abuse Treat; 2011 Oct; 41(3):252-60. PubMed ID: 21696913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17.
    Lim S; Cherian T; Katyal M; Goldfeld KS; McDonald R; Wiewel E; Khan M; Krawczyk N; Braunstein S; Murphy SM; Jalali A; Jeng PJ; MacDonald R; Lee JD
    Addiction; 2023 Mar; 118(3):459-467. PubMed ID: 36305669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study.
    Bech AB; Clausen T; Waal H; Šaltytė Benth J; Skeie I
    BMC Health Serv Res; 2019 Jul; 19(1):440. PubMed ID: 31266495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose severity.
    Shastry S; Nobel I; Allen LR; Richardson LD; Vidal K; Manini AF
    Am J Emerg Med; 2022 Jan; 51():114-118. PubMed ID: 34735968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.